Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...

Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

FORT MILL, SC / ACCESSWIRE / November 13, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced ...

Stereotaxis said physicians at the University of Kansas Health System successfully treated the first patients with its ...

The Top 12 IoT protocols Deployment of 5G and AI-enhanced IoT systems is accelerating. This, in turn, is driving up the ...

We detail why we think there’s confusion of frequency and magnitude in the case of Getinge. Click here to read more.

So, although De La Rue’s share price has rallied 75 per cent in the past 12 months, a sum-of-the-parts valuation suggests scope for a further 50 per cent upside to the £31.6mn carrying value of the ...

PAR made substantial progress in its Phase 3 clinical trial preparations for the treatment of knee osteoarthritis (OA) with ...

Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company", "Kane Biotech") announces today that it has entered into a binding term sheet (the "Term ...